Gut bacteria influences drug-induced liver injury

September 11, 2017
Gut bacteria influences drug-induced liver injury
Illustration shows that the drug metabolite (tacrine N-glucuronide) is metabolised by a bacterium to regenerate parent tacrine in the intestine. Credit: National University of Singapore

Pharmaceutical drugs are broken down by enzymes in the liver into their metabolites, which are subsequently excreted in the faeces and urine. Drugs can also undergo chemical reactions mediated by bacteria within the gut, an important process that is commonly neglected. In a new study, a team of pharmaceutical scientists from NUS found that gut bacteria may selectively modify the breaking down of a drug. This causes certain patients to suffer from drug-induced liver injury (DILI), where there are unexpected side effects from consuming a drug, causing liver damage. The discovery and understanding of this process could potentially lead to the development of novel strategies to improve drug treatment outcomes and reduce drug-associated side effects.

The study, led by Prof Eric CHAN from the Department of Pharmacy, NUS was carried out using tacrine, an anti-Alzheimer's disease which may cause unintended liver damage. The research was carried out in collaboration with scientists from GlaxoSmithKline, Department of Microbiology (NUS), Department of Surgery (NUS) and Genome Institute of Singapore (A*STAR).

"To date, the influence of microbes on the fate of drugs is only established for a small fraction of marketed medicines. The contribution of towards variation in the response of individuals to a given drug remains poorly understood. This difference in the response to drug therapy is clinically important and poses a major challenge to both drug development and patient management," said Prof Chan.

The research team found that rats suffering from DILI (DILI rats) experienced a process termed "enhanced enterohepatic recycling", where the excreted metabolite of the drug in bile is reconverted back to the parent drug by and reabsorbed into the body from within the gut. The DILI rats were found to have a greater amount of a specific bacteria that can enable this drug reconversion process. When this bacteria is made inactive, the research team found that there is less injury to the liver.

Dr YIP Lian Yee, who is the first author of the study, elaborated, "Our study establishes the gut microbial influences which cause unintended liver damage when using the drug tacrine, providing crucial insights for the development of personalised medicine initiatives."

"Our study confirms for the first time that the liver-gut microbial community has an influence on unintended damage caused by tacrine in rodent models. While this study is focused on tacrine, our findings hold pertinent implications for other therapeutic drugs with side effects, particularly those that undergo extensive enterohepatic recycling, demonstrate large variations between individuals and exhibit narrow therapeutic indices," said Prof Chan.

Explore further: Fatality rates are high within two years of drug-induced liver injury

More information: Lian Yee Yip et al. The Liver-Gut Microbiota Axis Modulates Hepatotoxicity of Tacrine in the Rat, Hepatology (2017). DOI: 10.1002/hep.29327

Related Stories

Fatality rates are high within two years of drug-induced liver injury

June 26, 2017
Most patients suffering liver toxicity due to medications or herbal or dietary supplements recover from the acute liver injury without long-term problems, but some do not survive the injury or they require liver transplantation. ...

Drug-induced liver injury from chinese, western meds varies

February 29, 2016
(HealthDay)—Chinese herbal medicine (CHM) and Western medicine (WM) have different effects as causes of drug-induced liver injury (DILI), according to a study published online Feb. 20 in the Journal of Gastroenterology ...

Genetic variation linked to drug-induced liver damage in some patients

February 22, 2017
Scientists have discovered an uncommon genetic variation that may identify patients with a higher risk of liver damage associated with a range of commonly-prescribed medications.

ACG: Drug-induced liver injury mainly due to antimicrobials

October 20, 2014
(HealthDay)—Idiosyncratic drug-induced liver injury (DILI) is mainly caused by antimicrobials and herbal and dietary supplements (HDS), according to research presented at the annual meeting of the American College of Gastroenterology, ...

Individual adverse drug responses could be predicted by a simple blood test

May 31, 2017
Severe illnesses sometimes require treatment regimens carrying grave risks, including organ failure. Now, a non-invasive technique developed at A*STAR could help predict patient vulnerability to potentially toxic drugs. 

Genetically modifying zebrafish for detection of harmful compounds in drug candidates

July 26, 2017
The common zebrafish is a useful proxy for testing whether drug candidates cause organ damage. Now, researchers in Singapore have created two modified types of the fish, one that glows when experiencing toxicity, and another ...

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.